908 Devices Inc. (NASDAQ:MASS) Is Favoured by Institutional Owners Who Hold 57% of the Company
908 Devices to Participate in Craig-Hallum Bioprocessing Conference
908 Devices Updates Investors With New Presentation
The Price Is Right For 908 Devices Inc. (NASDAQ:MASS) Even After Diving 29%
Buy Rating Affirmed for 908 Devices on Strong Market Position and Growth Prospects
TD Cowen Maintains 908 Devices(MASS.US) With Buy Rating
TD Cowen analyst Steven Mah maintains $908 Devices(MASS.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 27.4% and a total average return of -10.9% over the past
TD Cowen Sticks to Their Buy Rating for 908 Devices (MASS)
908 Devices | 10-Q: Q2 2024 Earnings Report
908 Devices GAAP EPS of -$0.37 Misses by $0.03, Revenue of $14B Beats by $13.99B
908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates
908 Devices 2Q Loss $12.5M >MASS
908 Devices 2Q Rev $14M >MASS
Earnings Flash (MASS) 908 DEVICES Reports Q2 Revenue $14M, Vs. Street Est of $13.7M
Express News | 908 Devices Reports Second Quarter 2024 Financial Results and Reiterates 2024 Revenue Outlook
Express News | 908 Devices Q2 Gross Profit USD 7.418 Million
Express News | 908 Devices Q2 EPS USD -0.37
Express News | 908 Devices Q2 Net Income USD -12.548 Million Vs. IBES Estimate USD -11.5 Million
Express News | 908 Devices Outlook FY Revenue USD 63-65 Million
Express News | 908 Devices Q2 Operating Expenses USD 20.978 Million
Calendar of U.S. Earnings Expected in the Week Ahead